TD Cowen on Boston Scientific (BSX): 'we do not anticipate any major changes to consensus estimates for BSX in the near term'
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $115.00 price target on Boston Scientific (NYSE: BSX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
